Research Topics
Genomes and Genes | H OhgakiSummaryAffiliation: International Agency for Research on Cancer Country: France Publications
| Collaborators
|
Detail Information
Publications
Effect of intragastric application of N-methylnitrosourea in p53 knockout miceH Ohgaki
Unit of Molecular Pathology, International Agency for Research on Cancer, Lyon, France
Mol Carcinog 28:97-101. 2000..004), suggesting a slightly higher susceptibility to gastric carcinogenesis induced by MNU in p53(+/-) mice. Mol. Carcinog. 28:97-101, 2000...
Genetic pathways to glioblastoma: a population-based studyHiroko Ohgaki
International Agency for Research on Cancer, Lyon, France
Cancer Res 64:6892-9. 2004..0208). This suggests that the acquisition of TP53 mutations in these glioblastoma subtypes occurs through different mechanisms...
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomasHiroko Ohgaki
Pathology Group, International Agency for Research on Cancer HO, F 69372, Lyon, France
J Neuropathol Exp Neurol 64:479-89. 2005..G:C-->A:T mutations at CpG sites were more frequent in secondary than primary glioblastomas, suggesting that the acquisition of TP53 mutations in these glioblastoma subtypes may occur through different mechanisms...
Correlation among pathology, genotype, and patient outcomes in glioblastomaTaku Homma
Pathology Group, International Agency for Research on Cancer, Lyon, France
J Neuropathol Exp Neurol 65:846-54. 2006..These results suggest that some histologic features in glioblastomas are associated with specific genetic alterations and with clinical outcome...
Molecular classification of low-grade diffuse gliomasYoung Ho Kim
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Am J Pathol 177:2708-14. 2010..8737). The molecular classification on the basis of IDH1/2 mutation, TP53 mutation, and 1p/19q loss has power similar to histological classification and avoids the ambiguity inherent to the diagnosis of oligoastrocytoma...
The definition of primary and secondary glioblastomaHiroko Ohgaki
Molecular Pathology Section, International Agency for Research on Cancer, Lyon, France
Clin Cancer Res 19:764-72. 2013..Despite a similar histologic appearance, primary and secondary glioblastomas are distinct tumor entities that originate from different precursor cells and may require different therapeutic approaches...
Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomasJingmei Liu
Department of Radiation Oncology, The Cancer Institute of New Jersey, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA
BMC Cancer 9:268. 2009..In this study, we investigated whether BCCIP is altered in astrocytomas...
Epidemiology and etiology of gliomasHiroko Ohgaki
International Agency for Research on Cancer, Lyon, France
Acta Neuropathol 109:93-108. 2005....
Genetic pathways to glioblastomasHiroko Ohgaki
International Agency for Research on Cancer, Lyon, France
Neuropathology 25:1-7. 2005....
APC mutations are infrequent but present in human lung cancerHiroko Ohgaki
Unit of Molecular Pathology, International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon 69372, France
Cancer Lett 207:197-203. 2004..These results suggest that disruption of the Wnt pathway through APC mutations is infrequent, but may be involved in the pathogenesis of a small subset of human lung carcinomas...
Genetic alterations and signaling pathways in the evolution of gliomasHiroko Ohgaki
International Agency for Research on Cancer, Lyon, France
Cancer Sci 100:2235-41. 2009..In this review, we summarize the current status of genetic alterations and signaling pathways operative in the evolution of astrocytic and oligodendroglial tumors...
Nervous system tumors associated with familial tumor syndromesHiroko Ohgaki
International Agency for Research on Cancer IARC, Lyon, France
Curr Opin Neurol 23:583-91. 2010..In this review, we provide a brief overview of these syndromes...
Genetic profile of astrocytic and oligodendroglial gliomasHiroko Ohgaki
Molecular Pathology Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, France
Brain Tumor Pathol 28:177-83. 2011....
Brain tumors in S100beta-v-erbB transgenic ratsHiroko Ohgaki
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
J Neuropathol Exp Neurol 65:1111-7. 2006....
Genetic pathways to primary and secondary glioblastomaHiroko Ohgaki
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Am J Pathol 170:1445-53. 2007..This has significant implications, particularly for the development of novel, targeted therapies, as discussed in this review...
Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomasR M Reis
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, France
Acta Neuropathol 101:297-304. 2001..These results suggest that mutations in these mitotic spindle checkpoint genes do not play a significant role in the causation of chromosomal instability in glioblastomas...
p14ARF deletion and methylation in genetic pathways to glioblastomasM Nakamura
International Agency for Research on Cancer, Lyon, France
Brain Pathol 11:159-68. 2001....
Promoter hypermethylation and homozygous deletion of the p14ARF and p16INK4a genes in oligodendrogliomasT Watanabe
Unit of Molecular Pathology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, France
Acta Neuropathol 101:185-9. 2001....
Promoter hypermethylation of the RB1 gene in glioblastomasM Nakamura
International Agency for Research on Cancer, Lyon, France
Lab Invest 81:77-82. 2001..These results indicate that promoter hypermethylation is a late event during astrocytoma progression and is the major mechanism underlying loss of RB1 expression in glioblastomas...
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor geneM Nakamura
International Agency for Research on Cancer, F-69372 Lyon, France
Carcinogenesis 22:1715-9. 2001....
Reduced expression of the Aalpha subunit of protein phosphatase 2A in human gliomas in the absence of mutations in the Aalpha and Abeta subunit genesS Colella
International Agency for Research on Cancer (IARC, Lyon, France
Int J Cancer 93:798-804. 2001..By comparison, the levels of the Balpha and Calpha subunits were mostly normal. Our data indicate that these tumors contain very low levels of core and holoenzyme and high amounts of unregulated catalytic C subunit...
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomasYoshikazu Okamoto
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France
Acta Neuropathol (Berl) 108:49-56. 2004..Multivariate Cox's regression analysis indicates that only age and histological type, but not genetic alterations, are significant predictive factors...
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomasTakuya Watanabe
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, France
Am J Pathol 174:1149-53. 2009....
Phenotype vs genotype in the evolution of astrocytic brain tumorsP Kleihues
International Agency for Research on Cancer, World Health Organization, Lyon, France
Toxicol Pathol 28:164-70. 2000....
Second primary glioblastomaR M Reis
International Agency for Research on Cancer, Lyon, France
J Neuropathol Exp Neurol 60:208-15. 2001..The presence in these neoplasms of multiple mutations in tumor suppressor genes suggests the involvement of a novel disease mechanism but there was no indication of a DNA mismatch repair deficiency or of an inherited tumor syndrome...
Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomasT Watanabe
International Agency for Research on Cancer, Lyon, France
J Neuropathol Exp Neurol 60:1181-9. 2001..Thus, simultaneous disruption of the RB1/CDK4/p16INK4a/p15INK4b and the TP53/p14ARF/MDM2 pathways occurs in 45% (9/20) of anaplastic oligodendrogliomas, suggesting that these phenomena contribute to their malignant phenotype...
APC mutations in sporadic medulloblastomasH Huang
International Agency for Research on Cancer, Lyon, France
Am J Pathol 156:433-7. 2000..Although germline APC mutations are a well established cause of familial colon and brain tumors (Turcot syndrome), this study provides the first evidence that APC mutations are also operative in a subset of sporadic medulloblastomas...
Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutationsTakuya Watanabe
International Agency for Research on Cancer, Lyon, France
J Neuropathol Exp Neurol 68:210-5. 2009..These results suggest that multiple TP53 mutations in glioblastomas are due to deficient repair of DNA double-strand breaks caused by mutational inactivation of the NBS1 gene...
Epidemiology of brain tumorsHiroko Ohgaki
Pathology Group, International Agency for Research on Cancer, Lyon, France
Methods Mol Biol 472:323-42. 2009....
Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomasIzabela Zawlik
International Agency for Research on Cancer, 150 cours Albert Thomas, Lyon, France
Brain Pathol 19:188-94. 2009..07-1.71). Detailed analyses revealed that TP53 codon 72 Pro allele was significantly associated with shorter survival among patients with glioblastomas carrying a TP53 mutation, and among those treated with surgery plus radiotherapy...
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomasSumihito Nobusawa
International Agency for Research on Cancer, Lyon, France
Clin Cancer Res 15:6002-7. 2009....
Endogenous deoxyribonucleic Acid (DNA) damage in human tissues: a comparison of ethenobases with aldehydic DNA lesionsAlain Barbin
International Agency for Research on Cancer, Lyon, France
Cancer Epidemiol Biomarkers Prev 12:1241-7. 2003..These data are in line with previous studies showing that brain tissues are more susceptible to oxidative stress and lipid peroxidation than other tissues...
PTEN methylation and expression in glioblastomasNathalie Baeza
International Agency for Research on Cancer (IARC, 69372, Lyon, France
Acta Neuropathol (Berl) 106:479-85. 2003....
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosisYoshihiro Edamoto
Unit of Molecular Pathology, International Agency for Research on Cancer (IARC, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Int J Cancer 106:334-41. 2003..e., chronic liver injury and cirrhosis, but tumors associated with alcoholism had more frequent alterations in the RB1 and p53 pathways than those caused by HCV infection...
Germline SDHD mutation in paraganglioma of the spinal cordJ Masuoka
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon, Cedex 08, France
Oncogene 20:5084-6. 2001..This is the first observation indicating that inherited SDHD mutations may occasionally cause the development of paragangliomas in the central nervous system...
Genetic evidence of the neoplastic nature of gemistocytes in astrocytomasR M Reis
Unit of Molecular Pathology, International Agency for Research on Cancer (IARC, Lyon, France
Acta Neuropathol 102:422-5. 2001..In all cases, identical TP53 mutations were identified in both cell types, indicating that gemistocytes are indeed neoplastic cells. Their lack of proliferative activity may indicate terminal differentiation...
Altered expression of immune defense genes in pilocytic astrocytomasHerve Huang
International Agency for Research on Cancer, Lyon, France, and Department of Neurosurgery, University of Zurich, Zurich, Switzerland
J Neuropathol Exp Neurol 64:891-901. 2005....
Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) miceWei Min Tong
International Agency for Research on Cancer IARC, Lyon, France
Am J Pathol 162:343-52. 2003..These PARP-1/p53 double null mice represent a novel model for the pathogenesis of human medulloblastomas...
Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomasTakao Watanabe
Unit of Molecular Pathology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Acta Neuropathol (Berl) 103:267-75. 2002..There was no correlation with LOH on chromosomes 1p/19q, suggesting that MGMT may not be a prognostic marker for oligodendrogliomas...
A population-based study of the incidence and survival rates in patients with pilocytic astrocytomaChristoph Burkhard
International Agency for Research on Cancer, Lyon, France
J Neurosurg 98:1170-4. 2003....
Age as a predictive factor in glioblastomas: population-based studyDaisuke Kita
International Agency for Research on Cancer, Lyon, France
Neuroepidemiology 33:17-22. 2009....
Selective acquisition of IDH1 R132C mutations in astrocytomas associated with Li-Fraumeni syndromeTakuya Watanabe
Pathology Group, International Agency for Research on Cancer, Lyon, France
Acta Neuropathol 117:653-6. 2009..This remarkably selective occurrence of R132C mutations may reflect differences in the sequence of genetic events, with a preference for R132C mutations in astrocytes or precursor cells that already carry a germline TP53 mutation...
Methylation of the p73 gene in gliomasTakao Watanabe
Unit of Molecular Pathology, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
Acta Neuropathol (Berl) 104:357-62. 2002..Analysis of a polymorphic site in exon 2 further showed that p73 was mono-allelically expressed in 6 out of 7 primary gliomas with heterozygous GC/TA polymorphism...
Lung fibre burden in lung cancer cases employed in the rock and slag wool industryK Soldan
International Agency for Research on Cancer, Lyon, France
Ann Occup Hyg 50:241-8. 2006....
Intratumoral patterns of genomic imbalance in glioblastomasSumihito Nobusawa
International Agency for Research on Cancer, Lyon, France
Brain Pathol 20:936-44. 2010....
TP53 promoter methylation in human gliomasVishwa Jeet Amatya
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Cedex 08, Lyon, France
Acta Neuropathol (Berl) 110:178-84. 2005....
Beta-catenin mutations in liver tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in CDF1 miceHerve Huang
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon 08, France
Cancer Lett 198:29-35. 2003....
Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based studyIzabela Zawlik
International Agency for Research on Cancer, Lyon, France
Neuroepidemiology 32:21-9. 2009..70; 95% CI 0.48-1.01). These results suggest that MGMT methylation may be associated with susceptibility to acquire TP53 G:C-->A:T mutations, and that MGMT polymorphisms may affect the risk and prognosis of glioblastomas...
PIK3CA alterations in primary (de novo) and secondary glioblastomasDaisuke Kita
International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France
Acta Neuropathol 113:295-302. 2007..These results suggest that the EGFR/PTEN/PI3K pathway is frequently altered in glioblastomas and is a promising target for therapy, in particular for primary glioblastomas...
Oxidative and nitrative stress caused by subcutaneous implantation of a foreign body accelerates sarcoma development in Trp53+/- miceHiroshi Tazawa
International Agency for Research on Cancer, 150 Cours Albert Thomas 69008 Lyon, France
Carcinogenesis 28:191-8. 2007..Such implant-induced sarcoma development in Trp53+/- mice could be useful for studying molecular mechanisms and developing new strategies for chemoprevention in human carcinogenesis induced by chronic inflammation and/or foreign bodies...
Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formationWei Min Tong
International Agency for Research on Cancer IARC, 69008 Lyon, France
Cancer Res 62:6990-6. 2002....
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotypeMagali Olivier
IARC, Lyon, Cedex 8, France
Cancer Res 63:6643-50. 2003..004). These observations have clinical implications for genetic testing and tumor surveillance in LFS/LFL families...
Genetic and expression profiles of cerebellar liponeurocytomasSonja Horstmann
International Agency for Research on Cancer, Lyon, France
Brain Pathol 14:281-9. 2004..Furthermore, the cDNA expression array data suggest a relationship to central neurocytomas, but the presence of TP53 mutations, which are absent in central neurocytomas, suggests that their genetic pathways are different...
Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomasWojciech Biernat
International Agency for Research on Cancer, 150 cours Albert Thomas, 60372 Lyon, France
Brain Pathol 14:131-6. 2004....
Mutations in the Nijmegen breakage syndrome gene in medulloblastomasJian Huang
IARC, Lyon, France
Clin Cancer Res 14:4053-8. 2008..There may be functional interactions between NBS1 and the TP53 pathways. The objective of the present study is to assess whether NBS1 mutations play a role in the pathogenesis of sporadic medulloblastomas...
AXIN1 mutations but not deletions in cerebellar medulloblastomasNathalie Baeza
International Agency for Research on Cancer, Lyon, France
Oncogene 22:632-6. 2003..Since there are multiple complementary, inverted sequences present in the AXIN1 gene, these large deletions may represent RT-PCR errors due to stem-loop secondary structures...
Genetic alterations in the PI3K pathway in prostate cancerXiuju Sun
International Agency for Research on Cancer, Lyon, France
Anticancer Res 29:1739-43. 2009..Glands of Gleason pattern 3 are genetically heterogeneous, some containing the same genetic alterations observed in glands of Gleason pattern 4...
Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53-deficient mice lacking inducible nitric oxide synthase geneMasayuki Tatemichi
International Agency for Research on Cancer, Lyon, France
Int J Cancer 111:819-28. 2004..While iNOS may have protective effects against nonthymic lymphomagenesis, the regulation of cytokine production by iNOS may be involved in the underlying mechanism of antilymphomagenesis effects in the peripheral lymphoid organ...
Whole genome amplification for array comparative genomic hybridization using DNA extracted from formalin-fixed, paraffin-embedded histological sectionsJian Huang
International Agency for Research on Cancer, Lyon, France
J Mol Diagn 11:109-16. 2009..0001). These results suggest that genetic analyses are possible using WGA-DNA extracted from paraffin sections, but that they should be performed with a carefully optimized and controlled protocol...
Gene expression profiling and subgroup identification of oligodendrogliomasHerve Huang
International Agency for Research on Cancer IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
Oncogene 23:6012-22. 2004..048). These results demonstrate that oligodendrogliomas and low-grade astrocytomas differ in their gene expression profiles, and that there are subgroups of oligodendroglioma with distinct expression profiles related to clinical outcome...
Granular cell astrocytomas show a high frequency of allelic loss but are not a genetically defined subsetAmilcar A Castellano-Sanchez
Department of Pathology, Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
Brain Pathol 13:185-94. 2003..Instead, it appears that granular cell change occurs across genetic subsets. The high frequency of allelic loss, especially on 9p and 10q, may confer aggressive growth potential and be related to their rapid clinical progression...
Stratification of medulloblastoma on the basis of histopathological gradingFelice Giangaspero
Department of Experimental Medicine and Pathology, University of Rome La Sapienza, 00151, Rome, Italy
Acta Neuropathol (Berl) 112:5-12. 2006..These findings indicate that degree of anaplasia is the most significant histologic feature predictive of the survival of medulloblastoma patients...
Molecular pathogenesis of astrocytic tumoursKoichi Ichimura
Department of Pathology, University of Cambridge, Cambridge, UK
J Neurooncol 70:137-60. 2004....
Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastomaJörg Wischhusen
Laboratories of Molecular Neuro Oncology, Institute for Cell Biology, University of Tubingen, 72076 Tubingen, Germany
Cancer Res 62:2592-9. 2002..Thus, induction of B-cell and T-cell apoptosis via interactions of CD70 expressed on glioma cells and CD27 expressed on B and T cells may be a novel way for the immune escape of malignant gliomas...
Congenital glioblastoma: a clinicopathologic and genetic analysisDaniel J Brat
Departments of Pathology and Laboratory Medicine and Winship Cancer Institute, Emory University School of Medicine, 1364 Clifton Road NE, Atlanta, GA 30322, USA
Brain Pathol 17:276-81. 2007..Nonetheless, the strong nuclear expression of p53 in these and other pediatric GBMs could indicate that p53 dysregulation is important to tumorigenesis...
